Prostate Cancer Biomarkers and PVSA Research Presented
Fellow Health showcased innovative research, emphasizing mail-in semen testing to enhance prostate cancer diagnostics and PVSA care.
Read MorePosted by Chris Wolski | Apr 30, 2025 | Prostate |
Fellow Health showcased innovative research, emphasizing mail-in semen testing to enhance prostate cancer diagnostics and PVSA care.
Read MorePosted by Chris Wolski | Apr 25, 2025 | Prostate |
Veracyte has launched Decipher Prostate test, a Medicare-covered test for guiding treatment in metastatic prostate cancer.
Read MorePosted by Chris Wolski | Apr 23, 2025 | Prostate |
A new study confirms Cleveland Diagnostics’ IsoPSA test effectively differentiates between low- and high-risk prostate cancer patients.
Read MorePosted by Chris Wolski | Apr 22, 2025 | Cancer |
Liquid biopsy is a groundbreaking, non-invasive method for early cancer detection and monitoring, offering significant clinical potential.
Read MorePosted by Chris Wolski | Apr 21, 2025 | Prostate |
Decipher Prostate Genomic Classifier data is included in a new SEER Program database, enabling the study of prostate cancer outcomes.
Read More